Table 3 Multinomial logistic regression analysis of differences among BMI trajectory groups (LBSI as the reference group).

From: Trajectory analysis of BMI increase induced by second-generation antipsychotics in first-episode schizophrenia: a secondary analysis based on CNFEST****

 

MBGI

LBRI

HBSI

OR (95% CI)

p-value

OR (95% CI)

p-value

OR (95% CI)

p-value

BMI_z-scorea

3.800 (2.472, 5.841)

<0.001

0.502 (0.209, 1.210)

0.125

15.976 (8.206, 31.102)

<0.001

PSP_z-scorea

1.522 (1.125, 2.058)

0.006

1.217 (0.690, 2.145)

0.498

1.723 (1.064, 2.791)

0.027

DUP

<1 vs. ≥1

1.162 (0.647, 2.086)

0.616

4.119 (1.312, 12.929)

0.015

0.539 (0.194, 1.496)

0.235

Antipsychotic regimen

Olanzapine vs. Risperidone

2.688 (1.332, 5.405)

0.006

2.740 (0.849, 8.850)

0.092

0.681 (0.194, 2.392)

0.549

Olanzapine vs. Aripiprazole

3.876 (1.894, 7.937)

<0.001

20.408 (2.481, 166.667)

0.005

0.533 (0.148, 1.919)

0.336

  1. aThe z-scores represented standardized continuous variables, thereby eradicating dimensional discrepancies in the original data and facilitating direct comparisons among continuous variables. The bold values correspond to factors that make a significant contribution to subgrouping.
Back to article page